PHOTO: BKASH

STAR BUSINESS DESK

Aristopharma Limited, one of the country’s leading pharmaceutical companies, has recently signed an agreement with bKash Limited, the leading mobile financial service (MFS) provider in Bangladesh to disburse payments directly to its stakeholders through bKash.

The initiative is expected to simplify field-level financial management, making it more transparent and secure.

It will also support the development of a cashless ecosystem by reducing the risks associated with handling physical cash.

Mohammad Sahid Hassan, deputy managing director of Aristopharma Limited, and Ali Ahmmed, chief commercial officer of bKash Limited, signed the agreement at the drug maker’s head office in Dhaka, according to a press release.

As part of the agreement, Aristopharma will use bKash’s “Disbursement Solution” to send payments directly to stakeholders’ bKash accounts.

Recipients will be able to cash out funds from bKash agent points or ATM booths nationwide.

Alternatively, they can use their balances digitally for a range of services, including merchant payments, utility bill payments (gas, electricity and water), money transfers and mobile recharges.

They can also pay educational or government fees, open DPS accounts in banks, purchase travel tickets and make donations.

Ahmed Imtiaz Hassan, director of Aristopharma; Md Maminul Islam, executive director and company secretary; Mohammad Siddiqul Alam Sikder, executive director; Masrur Chowdhury, head of business sales at bKash; and Md Somel Reza Khan, general manager of the business sales department, were also present at the event.